|
|
Volumn 68, Issue 5, 1999, Pages 701-704
|
|
Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CREATININE;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MONOCLONAL ANTIBODY;
RAPAMYCIN;
STEROID;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CREATININE BLOOD LEVEL;
CYTOKINE RELEASE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
MALE;
PRIORITY JOURNAL;
STEROID THERAPY;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
RECEPTORS, INTERLEUKIN-2;
SIROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0033567982
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/00007890-199909150-00018 Document Type: Article |
|
Times cited : (70)
|
|
References (16)
|
